Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
2invest AG is a Germany-based investment company that acquires, holds, manages, and sells investments in corporations and partnerships, primarily within the biotechnology, life sciences, and information technology sectors, both domestically and internationally. The company was formerly known as 4basebio AG and rebranded to 2invest AG in January 2021. Headquartered in Heidelberg, Germany, 2invest AG focuses on identifying and supporting emerging companies with strong management teams and innovative technologies, aiming to enable these companies to reach significant value inflection points.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
2invest AGEli Lilly
Last price
€6.90$1,427.28
Currency
EUR
USD
€38M$1.3T
-46.65
-€1.60$30.81
-0.020.39
0$6.69
00.48%
Sector
HealthHealth
Employees
450,000
Ticker
€2INV$LLY
Primary listing
XETRANYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €2INV or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.